Page last updated: 2024-10-30

mesalamine and Icterus

mesalamine has been researched along with Icterus in 2 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, M1
Najima, M1
Morizane, C1
Ueno, H1
Okusaka, T1
Nayar, M1
Cunliffe, W1
Cross, P1
Oppong, K1

Reviews

1 review available for mesalamine and Icterus

ArticleYear
[Palliative therapy in patients with biliary tract cancer].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 1

    Topics: Abdominal Pain; Analgesics; Antineoplastic Agents; Back Pain; Biliary Tract Neoplasms; Drainage; Fee

2006

Other Studies

1 other study available for mesalamine and Icterus

ArticleYear
Mesalazine-induced jaundice, eosonophilia, and thrombocytopenia.
    Inflammatory bowel diseases, 2008, Volume: 14, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Eosinophilia; Humans; Jaundice; Male;

2008